Particle.news
Download on the App Store

Man Survives Rattlesnake Bites After Local Hospital Exhausts Antivenom

A 54‑vial treatment followed by an urgent transfer to Stanford highlights how severe envenomations can overwhelm small hospitals, straining regional antivenom supplies.

Overview

  • Chris Howarth, visiting family in Oroville, was bitten twice by a rattlesnake on May 26, with one fang puncturing a vein and sending venom into his bloodstream.
  • Oroville Hospital gave repeated antivenom doses but by about day six had used 36 vials and the patient developed disseminated intravascular coagulation, a dangerous clotting disorder.
  • The hospital arranged an urgent air transfer to Stanford Medical Center the same day, where clinicians administered 18 more vials and provided transfusions during a 12‑day hospitalization.
  • Howarth returned home to Meridian, Idaho, in June but remains unable to work and is recovering from lingering symptoms while his family has launched a GoFundMe to help with expenses.
  • State officials say most snakebites need only a few vials but dosing can vary widely, and hospitals without large antivenom stocks must call suppliers, consult poison control, or transfer patients, a challenge made sharper this season by increased rattlesnake activity after a March heat wave.